Ekso Bionics (EKSO) Reports Q4 Loss of $0.15/Share

Ekso Bionics (NASDAQ: EKSO) reported Q4 EPS of ($0.15), versus ($0.34) reported last year. Revenue for the quarter came in at $2.5 million, versus $2.6 million reported last year.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Financial Select Sector SPDR ETF (XLF) spreader of 20K contracts of July 31 weekly 57 and 59 calls into bank earnings season
• Piper Sandler on FirstSun Capital Bancorp (FSUN): 'We expect shares to underperform on Friday'